Xenetic Biosciences (XBIO) Reports Q2 Loss of $0.34/Share

Xenetic Biosciences (NASDAQ: XBIO) reported Q2 EPS of ($0.34), versus ($6.12) reported last year.

For earnings history and earnings-related data on Xenetic Biosciences (XBIO) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Six Flags names Mark Pauls as chief operating officer
• RBC Capital Upgrades GEA Group AG (G1A:GR) (GEAGY) to Outperform